Health and Healthcare
Health and Healthcare Articles
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
Published:
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
Published:
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
Published:
Rarely does a disease spread fast enough and is labeled dangerous enough that it quickly gets the attention of the WHO. A coronavirus, which has killed several people in China and has spread to other...
Published:
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Published:
Last Updated:
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
Published:
Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon Therapeutics shareholders getting enough out of the deal?
Published:
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Published:
Last Updated:
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Published:
Last Updated:
When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.
Published:
Last Updated:
Some Americans believe that vaccinations are more dangerous than the diseases they prevent. The number is growing, says Gallup.
Published:
UnitedHealth is scheduled to report its most recent quarterly results before the opening bell on Wednesday.
Published:
Last Updated:
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
Published:
Adaptimmune shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.